Newsmeme!
Discover News you didn't know existed
Pulmonary Hypertension
News
Related Video News
No related video news stories found.
Related Videos
No related videos found.
Boy vows to hike Colorado 14ers to help friend
Published July 9, 2009, 3:33 pm, 9 News Denver
BOULDER - Matt Moniz and Iain Hess have been friends for as long as they can remember.
Revolutionary Heart Pump Saves Miami Woman's Life
Published July 9, 2009, 2:37 pm, CBS4 Miami
It wasn't that long ago that Orfelina Torres had a hard time taking a short walk and was prone to fainting spells. But now, thanks to a new device she carries around with her wherever she goes, the 58-year-old Torres has a new lease on life. The miracle device is called the Heart Mate II.
Efficacy Of Tecarfarin Mirrors Earlier Studies While Primary Endpoint Missed
Published July 9, 2009, 5:15 am, Medical News Today
ARYx Therapeutics, Inc. (NASDAQ:ARYX), a biopharmaceutical company, announced results from its Phase 2/3 clinical trial, EmbraceAC, comparing its novel anticoagulant agent tecarfarin (previously ATI-5923) with the leading oral anticoagulant warfarin.
What Is Heart Failure? What Causes Heart Failure?
Published July 9, 2009, 3:17 am, Medical News Today
Even though it may sound like it, heart failure does not necessarily mean that the heart has failed. Heart failure is a serious condition in which the heart is not pumping blood around the body efficiently. The patient's left side, right side, or even both sides of the body can be affected. Symptoms will depend on which side is affected and how severe the heart failure is - symptoms can be severe.
Sanofi Gets Green Light on Blockbuster Heart Treatment
Published July 8, 2009, 2:49 pm, Pharmaceutical Executive Magazine
Sanofi-Aventis is banking that its highly anticipated atrial fibrillation/flutter treatment Multaq will be a huge success. The path to approval has been ridden with a failed trial and a very long review process, but for Sanofi, the wait has been worth it.
New Drug Application For Exenatide Once Weekly Accepted For Review By FDA
Published July 8, 2009, 10:14 am, Medical News Today
Amylin Pharmaceuticals, Inc., (Nasdaq: AMLN), Eli Lilly and Company (NYSE: LLY) and Alkermes, Inc. (Nasdaq: ALKS) announced that the New Drug Application (NDA) for exenatide once weekly has been accepted for review by the U.S. Food and Drug Administration (FDA).
ARYx Therapeutics Announces Results of Phase 2/3 Clinical Trial on Anticoagulant Agent Tecarfarin
Published July 7, 2009, 7:00 pm, Business Wire via Yahoo! Finance
FREMONT, Calif.----ARYx Therapeutics, Inc. , a biopharmaceutical company, today announced results from its Phase 2/3 clinical trial, EmbraceAC, comparing its novel anticoagulant agent tecarfarin with the leading oral anticoagulant warfarin.
New Drug Application for Exenatide Once Weekly Accepted for Review by FDA
Published July 7, 2009, 4:13 pm, redOrbit
SAN DIEGO, INDIANAPOLIS and CAMBRIDGE, Mass., July 7 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc., (Nasdaq: AMLN), Eli Lilly and Company (NYSE: LLY) and Alkermes, Inc.
New Drug Application for Exenatide Once Weekly Accepted for Review by FDA
Published July 7, 2009, 1:06 pm, Business Wire via Yahoo! Finance
SAN DIEGO, INDIANAPOLIS & CAMBRIDGE, Mass.----Amylin Pharmaceuticals, Inc., , Eli Lilly and Company and Alkermes, Inc. today announced that the New Drug Application for exenatide once weekly has been accepted for review by the U.S.
Galway, Ireland
Published July 7, 2009, 6:52 am, Irish Emigrant
Gilead Sciences, which established an operation in Cork in 2007 as a result of its acquisition of the Nycomed Ltd manufacturing facility, is to open a a European Financial Shared Services Centre in the city.
Related News Resources:
> HGH News
News Directory
Get started fast by using a pre-defined news directory category
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |